The DOH's Bureau of Pharmaceutical Affairs states that DOH has received no reports of adverse reactions to the slimming drugs thus far authorized for sale in Taiwan, but it will continue to monitor them.
衛生署藥政處表示，至今核准上市的減肥藥，衛生署都沒有接獲不良反應的通報，他們將會持續注意。